October 2, 2020
The COVID-19 pandemic has made breast cancer patients even more vulnerable in their fight to defeat this illness. They are faced with many new limitations within their healthcare systems coupled with financial challenges in this uncertain economy. To support our ongoing commitment to joining the fight, SHG surveyed ~180 international Oncologists to bring forth the global impact COVID-19 continues to have on patient screening, diagnosis, and treatment recommendations. The Physicians participating in this survey agreed to donate their honorarium to their national organization for breast cancer research!
September 21, 2020
As the development of the COVID-19 vaccine advances, SurveyHealthcareGlobus (SHG) wanted to understand how primary care doctors globally were perceiving the receptivity of a potential vaccine for themselves, their patients, and their communities given recent insights and historical observations.
August 5, 2020
800 Physicians across North America + EU5 discuss their summer holiday plans amidst COVID-19, and their willingness to participate in MR research, including F2F. USA | CAN | UK | FRA | GER | ITA | SPA
August 5, 2020
Patients and physicians across the USA & EU5 discuss the future of virtual MD visits post COVID-19. Topics include effectiveness & quality of care compared to in-person visits, preferred technology methods, top therapeutic areas most commonly treated via tech platforms, & more. Could telehealth ultimately replace in-office visits? Find out what they said. USA | UK | FRA | GER | ITA | SPA
July 22, 2020
STAMFORD, CT, July 22, 2020—Saroras Private Capital (Saroras), a private equity investment firm focused on the technology-enabled services industry, has announced the establishment of Apollo Intelligence Corporation (Apollo), a platform company automating the creation of technology-driven data and insights solutions for research and marketing professionals in the life sciences and healthcare industries. Apollo currently operates InCrowd, Inc. (InCrowd), a pioneer of real-time, high-quality market intelligence for the life sciences industry...
May 20, 2020
SHG reached out to 190 HCPs in the hard hit regions of Italy & Spain to understand next steps and concerns regarding their country-specific plans for reopening after the COV19 Pandemic. We've compiled their insights on the increase of new patient COVID cases & deaths, hospital readiness for a second wave, post-pandemic learnings, and overall opinions on lockdown lift. Were we really ready?
May 14, 2020
QRCA recently conducted a study on the effect of physician willingness to participate in Qualitative Research. SHG provided the programming, hosting, recruitment, & honoraria. Methodology: Online LOI: 5 minutes Geography: USA Requirements: Spends 70%+ time in direct patient care Fielding Dates: April 9-21, 2020
May 11, 2020
12 Nurses from Around the Globe on Personal Experiences During Pandemic. PPE Availability & Protection | Opinions on Government Response | Results of Unrelated-Illness Cases | Plus Personal Sacrifices & Struggles
May 1, 2020
As the number of cases of COVID-19 increase, so does the associated anxiety... SurveyHealthcareGlobus paired up with Mental Health America (MHA) to help bring forth the importance of and issues surrounding mental health awareness. This year, we sharpened our focus on the mental health efforts of COVID-19; social distancing, self-isolation, and future-uncertainty.
March 29, 2020
On behalf of SurveyHealthcareGlobus, we would like to give a sincere, heartfelt thanks to all the healthcare professionals on the front lines serving us tirelessly each day! Today, on National Doctor's Day, we would like to release insights from 5 of our panel's healthcare heroes across different specialty areas. We hosted a virtual discussion on new and emerging trends within their specialties, their particular market research preferences, the impact of pharma advertising direct-to-consumer, as well the challenges facing their uninsured patients. We round out our Q&A with specialty-specific insights on COVID-19, with topics that include potential treatments on the horizon and alternatives to in-office care.